REL-P11 is a proprietary, low-dose, modified-release psilocybin formulation. Single-Ascending Dosing (SAD) study to evaluate safety and pharmacokinetics in obese and normal weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback